We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Nathan's Famous
NATH
$402M
| $296K | ﹤0.01% |
4,186
-800
| -16% | -$56K |
|
2527
Cass Information Systems
CASS
$743M
| $296K | ﹤0.01% |
6,137
-3,223
| -34% | -$146K |
|
2528
Spok Holdings
SPOK
$241M
| $292K | ﹤0.01% |
18,287
-124,841
| -87% | -$2.05M |
|
2529
VSE Corp
VSEC
$6.12B
| $292K | ﹤0.01% |
3,644
-26,492
| -88% | -$1.81M |
|
|
MOFG
2530
DELISTED
MidWestOne Financial Group
MOFG
| $291K | ﹤0.01% |
12,433
-1,232
| -9% | -$29.6K |
|
|
LOGC
2531
DELISTED
ContextLogic
LOGC
| $291K | ﹤0.01% |
51,062
-221,233
| -81% | -$1.22M |
|
2532
DaVita
DVA
$11.7B
| $290K | ﹤0.01% |
2,101
-50,753
| -96% | -$6.09M |
|
2533
Simply Good Foods
SMPL
$982M
| $289K | ﹤0.01% |
+8,503
| New | +$313K |
|
2534
Belden
BDC
$5.19B
| $288K | ﹤0.01% |
3,112
-2,788
| -47% | -$227K |
|
2535
Molina Healthcare
MOH
$10.3B
| $288K | ﹤0.01% |
700
| – | – |
|
2536
Prelude Therapeutics
PRLD
$390M
| $287K | ﹤0.01% |
60,597
+2,313
| +4% | +$9K |
|
2537
Xeris Biopharma Holdings
XERS
$1.45B
| $287K | ﹤0.01% |
129,864
+32,515
| +33% | +$84.1K |
|
2538
FS Bancorp
FSBW
$320M
| $287K | ﹤0.01% |
8,265
-1,017
| -11% | -$34.9K |
|
|
ATXS
2539
DELISTED
Astria Therapeutics
ATXS
| $286K | ﹤0.01% |
20,291
-13,756
| -40% | -$171K |
|
2540
Lincoln Educational Services
LINC
$1.3B
| $284K | ﹤0.01% |
27,532
-3,714
| -12% | -$36.2K |
|
2541
Sylvamo
SLVM
$1.63B
| $284K | ﹤0.01% |
4,600
-39,720
| -90% | -$2.12M |
|
2542
SiriusPoint
SPNT
$2.68B
| $283K | ﹤0.01% |
22,271
-28,800
| -56% | -$343K |
|
2543
Avient
AVNT
$4.19B
| $282K | ﹤0.01% |
6,507
-50,692
| -89% | -$1.98M |
|
2544
Inovio Pharmaceuticals
INO
$69M
| $281K | ﹤0.01% |
20,261
-7,163
| -26% | -$61.8K |
|
2545
First Business Financial Services
FBIZ
$595M
| $281K | ﹤0.01% |
7,499
+1,100
| +17% | +$39.6K |
|
2546
State Street SPDR S&P Homebuilders ETF
XHB
$1.62B
| $281K | ﹤0.01% |
2,520
-490
| -16% | -$49K |
|
2547
Compass Therapeutics
CMPX
$387M
| $280K | ﹤0.01% |
141,642
-51,058
| -26% | -$88.2K |
|
2548
BOK Financial
BOKF
$8.74B
| $279K | ﹤0.01% |
+3,036
| New | +$257K |
|
2549
Quanterix
QTRX
$190M
| $279K | ﹤0.01% |
11,837
-67,679
| -85% | -$1.68M |
|
2550
Boston Omaha
BOC
$436M
| $279K | ﹤0.01% |
18,033
-34,899
| -66% | -$549K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.